z-logo
Premium
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node–negative nasopharyngeal carcinoma
Author(s) -
Zeng Lei,
Sun XueMing,
Chen ChunYan,
Han Fei,
Huang Ying,
Xiao WeiWei,
Liu Shuai,
Tian YunMing,
Deng XiaoWu,
Lu TaiXiang
Publication year - 2014
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.23359
Subject(s) - medicine , nasopharyngeal carcinoma , radiation therapy , neck dissection , lymph node , lymph , head and neck cancer , surgery , radiology , carcinoma , pathology
Background The purpose of this study was to investigate the prophylactic irradiation volume to neck drainage areas for patients with N0 classification nasopharyngeal carcinoma (NPC) treated by intensity‐modulated radiotherapy (IMRT). Methods From January 2003 to October 2008, 270 patients with N0 classification (American Joint Committee on Cancer [AJCC] 2002 staging system) NPC who had undergone IMRT were retrospectively analyzed. Among all the patients, 171 patients received prophylactic upper‐neck irradiation, and 99 patients received prophylactic whole‐neck irradiation. Results At a median follow‐up of 65.1 months (range, 4–106 months). The 5‐year overall survival (OS), nodal recurrence–free survival (NRFS), and distant metastasis–free survival (DMFS) rates of the upper neck group and the whole neck group were 93.6% vs 90.9% ( p = .553), 99.4% vs 99.0% ( p = .278), and 98.8% vs 94.9% ( p = .128), respectively. A total of 3 neck recurrences were found, including 2 from the whole neck group and 1 from the upper neck group. The latter (0.6%) was an out‐of‐field recurrence. Conclusion Prophylactic irradiation to the upper neck (levels II, III, and VA) may be feasible for patients with neck lymph node‐negative NPC. © 2013 Wiley Periodicals, Inc. Head Neck 36 : 687–693, 2014

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here